Home > Insider Trading > Brainstorm Cell Therapeutics Inc.

Brainstorm Cell Therapeutics Inc. (BCLI)

Market is closed

Get Email Alerts

Profile
Hedge Fund Holdings
Insider Purchases
Insider Sales
Institutional Holdings
13 D/G Filings
News

Get Email Alerts

News

1 - 10
Next >>

Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI) Q4 2024 Earnings Call Transcript

Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI) Q4 2024 Earnings Call Transcript March 31, 2025Brainstorm Cell Therapeutics Inc. reports earnings inline with expectations.

Keep Reading →

April 1st, 2025 - News Transcripts

Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI) Q2 2024 Earnings Call Transcript

Operator: Greetings, and welcome to the Brainstorm Cell Therapeutics Second Quarter 2024 Conference Call. At this time, participants are in a listen-only mode.

Keep Reading →

August 15th, 2024 - News Transcripts

Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI) Q3 2023 Earnings Call Transcript

Operator: Greetings, and welcome to the BrainStorm Cell Therapeutics Third Quarter 2023 Earnings Call. At this time, participants are in a listen-only mode. As a reminder, this call is being recorded.

Keep Reading →

November 15th, 2023 - News Transcripts

Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI) Q2 2023 Earnings Call Transcript

Operator: Greetings, and welcome to the Brainstorm Cell Therapeutics Second Quarter 2023 Earnings Call. At this time, all participants are in a listen-only mode.

Keep Reading →

August 15th, 2023 - News Transcripts

Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI) Q1 2023 Earnings Call Transcript

Operator: Greetings, and welcome to the Brainstorm Cell Therapeutics First Quarter 2023 Earnings Call. At this time, participants are in a listen-only mode. As a reminder this call is being recorded.

Keep Reading →

May 17th, 2023 - News Transcripts

Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI) Q4 2022 Earnings Call Transcript

Operator: Greetings, and welcome to the Brainstorm Cell Therapeutics Fourth Quarter 2022 Earnings Call. At this time, all participants are in a listen-only mode.

Keep Reading →

April 5th, 2023 - News Transcripts

Is Brainstorm Cell Therapeutics Inc. (BCLI) A Good Stock To Buy?

Hedge Funds and other institutional investors have just completed filing their 13Fs with the Securities and Exchange Commission, revealing their equity portfolios as of the end of September.

Keep Reading →

June 22nd, 2021 - Hedge Funds News

Hedge Funds Aren't Crazy About Brainstorm Cell Therapeutics Inc. (BCLI) Anymore

Before we spend countless hours researching a company, we like to analyze what insiders, hedge funds and billionaire investors think of the stock first.

Keep Reading →

November 26th, 2020 - Hedge Funds News

Hedge Fund and Insider Trading News: Michael Tiedemann, Steve Cohen, BlueBay Asset Management, Brainstorm Cell Therapeutics Inc (BCLI), ADDvantage Technologies Group, Inc. (AEY), and More

THAT WORRY ACCOMPANIES WEALTH may seem paradoxical, but Michael Tiedemann says his firm’s 400-plus client households almost invariably fret about their heirs.

Keep Reading →

July 17th, 2020 - Hedge Funds Insider Trading

Hedge Funds Warming Up To Brainstorm Cell Therapeutics Inc. (BCLI)

We at Insider Monkey have gone over 821 13F filings that hedge funds and prominent investors are required to file by the SEC The 13F filings show the funds' and investors' portfolio positions as of March...

Keep Reading →

June 4th, 2020 - Hedge Funds News